Rock Springs Capital Management LP Argenx Se Transaction History
Rock Springs Capital Management LP
- $1.67 Billion
- Q1 2025
A detailed history of Rock Springs Capital Management LP transactions in Argenx Se stock. As of the latest transaction made, Rock Springs Capital Management LP holds 175,750 shares of ARGX stock, worth $103 Million. This represents 6.22% of its overall portfolio holdings.
Number of Shares
175,750
Previous 229,600
23.45%
Holding current value
$103 Million
Previous $141 Million
26.33%
% of portfolio
6.22%
Previous 5.64%
Shares
14 transactions
Others Institutions Holding ARGX
# of Institutions
497Shares Held
28.5MCall Options Held
330KPut Options Held
286K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.16 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.64 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.26 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.14 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$726 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32.5B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...